Neumora Therapeutics (NMRA) Other Non Operating Income (2022 - 2026)
Neumora Therapeutics' quarterly Other Non Operating Income came in at $59000.0 in Q1 2026, up 336.0% year-on-year from $13532.1 in Q1 2025, and up 121.93% quarter-over-quarter from -$269000.0 in Q4 2025.
Neumora Therapeutics has reported Other Non Operating Income for 5 years, with the latest figure at $59000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 336.0% year-over-year to $59000.0; the trailing twelve-month figure through Mar 2026 stood at -$683000.0 (down 650.55% YoY), and the FY2025 full-year result was -$767000.0, down 883.33% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $59000.0, up from -$269000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $287000.0 in Q4 2022, with the low at -$480000.0 in Q2 2025.
- Average Other Non Operating Income over 5 years is -$54466.7, with a median of -$25000.0 recorded in 2025.
- Year-over-year, Other Non Operating Income slumped 5600.0% in 2024 and surged 336.0% in 2026.
- Tracing NMRA's Other Non Operating Income over 5 years: stood at $287000.0 in 2022, then sank by 136.24% to -$104000.0 in 2023, then jumped by 114.42% to $15000.0 in 2024, then tumbled by 1893.33% to -$269000.0 in 2025, then soared by 121.93% to $59000.0 in 2026.
- The last three Other Non Operating Income figures came in at $59000.0 (Q1 2026), -$269000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Neumora Therapeutics | 328.27 Mn | 328.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | -269,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | -480,000.00 |
| Mar 31, 2025 | -25,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | -104,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -39,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | 287,000.00 |
| Sep 30, 2022 | -148,000.00 |